-
How much more are we willing to pay for a vaccine that can be used outside of the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good investment for national immunization programs?
This presentation will address these questions, presenting the key economic arguments in favour of CTC implementation from a country perspective.
https://youtu.be/eYZdTWh1IPQPublication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.